Novel biologically active nitro and amino substituted benzimidazo [1,2-a]quinolines

Bioorganic and Medicinal Chemistry

Volumn 19, Issue 21, 2011, Pages 6329-6339

  Perin, Nataša ^a   Uzelac, Lidija ^b   Piantanida, Ivo ^b   Karminski Zamola, Grace ^a   Kralj, Marijeta ^b   Hranjec, Marijana ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Antiproliferative activity; Benzimidazoles; Benzimidazo 1,2 a quinolines; Cytometry analysis; Interaction with ct DNA

Indexed keywords

2 (2 BENZIMIDAZOLYL) 3 (2 CHLORO 5 NITROPHENYL)ACRYLONITRILE; 2 [2 (5 (6) METHYL)BENZIMIDAZOLYL] 3 (2 CHLORO 5 NITROPHENYL)ACRYLONITRILE; 2 [2 (5 (6) NITRO)BENZIMIDAZOLYL] 3 (2 CHLORO 5 NITROPHENYL)ACRYLONITRILE; 2 [2 (5 (6) NITRO)BENZIMIDAZOLYL] 3 (2 CHLOROPHENYL)ACRYLONITRILE; 3 8(9) AMINO 6 CYANO BENZIMIDAZO[1,2 A]QUINOLINE HYDROCHLORIDE; 3 8(9) DIAMINO 5 CYANO BENZIMIDAZO[1,2 A]QUINOLINE; 3 8(9) DIAMINO CYANO BENZIMIDAZO[1,2 A]QUINOLINE HYDROCHLORIDE; 3 AMINO 5 CYANO BENZIMIDAZO[1,2 A]QUINOLINE; 3 AMINO 6 CYANO BENZIMIDAZO[1,2 A]QUINOLINE HYDROCHLORIDE; 3 AMINO 8(9) METHYL 6 CYANO BENZIMIDAZO[1,2 A]QUINOLINE; 3 AMINO 8(9) METHYL 6 CYANO BENZIMIDAZO[1,2 A]QUINOLINE HYDROCHLORIDE; 3 AMINO BENZIMIDAZO[1,2 A]QUINOLINE; 3 AMINO BENZIMIDAZO[1,2 A]QUINOLINE HYDROCHLORIDE; 3 NITRO 8(9) METHYL 6 CYANO BENZIMIDAZOL[1,2 A]QUINOLINE; 3 NITRO BENZIMIDAZOL[1,2 A]QUINOLINE; 3 NITRO CYANO BENZIMIDAZO[1,2 A]QUINOLINE; 3,8(9) DIAMINO BENZIMIDAZOL[1,2 A]QUINOLINE; 3,8(9) DINITRO 6 CYANO BENZIMIDAZOL[1,2 A]QUINOLINE; 3,8(9) DINITRO BENZIMIDAZOL[1,2 A]QUINOLINE; 8(9) AMINO 5 CYANO BENZIMIDAZO[1,2 A]QUINOLINE; 8(9) AMINO 6 CYANO BENZIMIDAZO[1,2 A]QUINOLINE HYDROCHLORIDE; 8(9) NITRO 6 CYANO BENZIMIDAZO[1,2 A]QUINOLINE; AMINO BENZIMIDAZO[1,2 A]QUINOLONE DERIVATIVE; AMINO BENZIMIDAZO[1,2 A]QUINOLONE HYDROCHLORIDE; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG; [2 [2 (CHLORO 5 NITROPHENYL)ETHENYL]]5(6) NITROBE BENZIMIDAZOLE; [2 [2 (CHLORO 5 NITROPHENYL)ETHENYL]]BENZIMIDAZOLE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL COUNT; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPLASM; DNA DAMAGE; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TARGETING; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; TUMOR CELL LINE; TUMOR GROWTH;

EID: 80054912361     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2011.09.002     Document Type: Article

References (27)

1. Yang, X. L.; Wang, A. H.-J. Pharmacol. Ther. 1999, 83, 181.
2. Silverman, R. B. The Organic Chemistry of Drug Design and Drug Action; 2nd ed.: Elsevier Academic Press, 2004.
3. Demeunynck, M.; Bailly, C.; Wilson, W. D. In D.N.A. and R.N.A. Binders; Wiley-VCH: Weinheim, 2002.
4. Lednicer, D. Strategis for Organic Drug Syntesis and Design; John Wiley & Sons: New York, 1998.
5. Martínez, V.; Burgos, V.; Alvarez-Builla, J.; Fernández, G.; Domingo, A.; Garcia-Nieto, R.; Gago, F.; Manzanares, I.; Cuevas, C.; Vaquero, J. J. J. Med. Chem. 2004, 47, 1136.
6. Pastor, J.; Siro, G.; García-Navío, J. L.; Vaquero, J. J.; Alvarez-Builla, J.; Gago, F.; Pascual-Teresa, B.; Pastor, M.; Rrodrigo, M. M. J. Org. Chem. 1997, 62, 5476.
7. Hranjec, M.; Starčević, K.; Piantanida, I.; Kralj, M.; Marjanović, M.; Hasani, M.; Westman, G.; Karminski-Zamola, G. Eur. J. Med. Chem. 2008, 43, 2877.
8. Starčević, K.; Kralj, M.; Ester, K.; Sabol, I.; Grce, M.; Pavelić, K.; Karminski-Zamola, G. Bioorg. Med. Chem. 2007, 15, 4419.
9. Yun-Fei, L.; Gui-Feng, W.; Yu, L.; Wei-Gang, H.; Tang, W.; Feng, C. L.; Shi, L. P.; Ren, Y. D.; Zuo, J. P.; Lu, W. Eur. J. Med. Chem. 2007, 42, 1358.
10. Ates-Alagoz, Z.; Yildiz, S.; Buyukbingol, E. Chemotherapy 2007, 53, 110.
11. Yadav, S.; Kumar, P.; De Clercq, E.; Balzarini, J.; Pannecouque, C.; Dewan, S. K.; Narasimhan, B. Eur. J. Med. Chem 2010, 45, 5985.
12. Grogan, H. M. Pest. Manag. Sci. 2006, 62, 153.
13. Velík, J.; Baliharová, V.; Fink-Gremmels, J.; Bull, S.; Lamka, J.; Skálová, L. Res. Vet. Sci. 2004, 76, 95.
14. Kucukguzel, I.; Kucukguzel, S. G.; Rollas, S.; Sanis, G. O.; Ozdemir, O.; Bayrak, I.; Altug, T.; Stables, J. Il Farmaco 2004, 59, 839.
15. Hranjec, M.; Kralj, M.; Piantanida, I.; Sedić, M.; Šuman, L.; Pavelić, K.; Karminski-Zamola, G. J. Med. Chem. 2007, 50, 5696.
16. Hranjec, M.; Piantanida, I.; Kralj, M.; Šuman, L.; Pavelić, K.; Karminski-Zamola, G. J. Med. Chem. 2008, 51, 4899.
17. Cox, O.; Jackson, H.; Vargas, V. A.; Bàez, A.; Colón, J. I.; Gonzalez, B. C.; De León, M. J. Med. Chem. 1982, 25, 1378.
18. Vivas-Mejía, P.; Rodríguez-Cabán, J. L.; Díaz-Velázquez, M.; Hernández-Pérez, M. G.; Cox, O.; Gonzalez, F. A. Mol. Cell. Biochem. 1997, 177, 69.
19. Vivas-Mejía, P.; Cox, O.; Gonzalez, F. A. Mol. Cell. Biochem. 1998, 178, 203.
20. Hranjec, M.; Pavlović, G.; Marjanović, M.; Kralj, M.; Karminski-Zamola, G. Eur. J. Med. Chem. 2010, 45, 2405.
21. Hranjec, M.; Lučić, B.; Ratkaj, I.; Kraljević Pavelić, S.; Piantanida, I.; Pavelić, K.; Karminski-Zamola, G. Eur. J. Med. Chem. 2011. doi:10.1016/ j.ejmech.2011.03.062.
22. Scatchard, G. Ann. N.Y. Acad. Sci. 1949, 51, 660;
23. McGhee, J. D.; von Hippel, P. H. J. Mol. Biol. 1976, 103, 679.
24. Rodger, A.; Norden, B. Circular Dichroism and Linear Dichroism; Oxford University Press: New York, 1997.
25. Eriksson, M.; Nordén, B. Methods Enzymol. 2001, 34, 68.
26. Chaires, J. B.; Dattagupta, N.; Crothers, D. M. Biochemistry 1982, 21, 3933;
27. Piantanida, I.; Palm, B. S.; Čudić, P.; Žinić, M.; Schneider, H. J. Tetrahedron 2004, 60, 6225.